GeneDx Holdings (WGS) Operating Leases (2022 - 2025)
Historic Operating Leases for GeneDx Holdings (WGS) over the last 4 years, with Q3 2025 value amounting to $57.2 million.
- GeneDx Holdings' Operating Leases fell 532.72% to $57.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.2 million, marking a year-over-year decrease of 532.72%. This contributed to the annual value of $60.9 million for FY2024, which is 850.94% down from last year.
- As of Q3 2025, GeneDx Holdings' Operating Leases stood at $57.2 million, which was down 532.72% from $59.6 million recorded in Q2 2025.
- In the past 5 years, GeneDx Holdings' Operating Leases ranged from a high of $69.1 million in Q2 2023 and a low of $57.2 million during Q3 2025
- In the last 4 years, GeneDx Holdings' Operating Leases had a median value of $63.4 million in 2022 and averaged $63.7 million.
- Per our database at Business Quant, GeneDx Holdings' Operating Leases surged by 892.78% in 2023 and then tumbled by 1200.39% in 2024.
- GeneDx Holdings' Operating Leases (Quarter) stood at $66.1 million in 2022, then increased by 0.68% to $66.6 million in 2023, then fell by 8.51% to $60.9 million in 2024, then decreased by 6.18% to $57.2 million in 2025.
- Its Operating Leases was $57.2 million in Q3 2025, compared to $59.6 million in Q2 2025 and $59.9 million in Q1 2025.